Clinical

Dataset Information

0

Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)


ABSTRACT: This is a phase Ib/II clinical study that has two phases. In phase Ib, the safety evaluation of the extract of Petiveria alliacea (Esperanza) will be carried out in patients with metastatic gastrointestinal tumors (colon, pancreas, stomach, and biliary tract) and patients with newly diagnosed and relapsed acute leukemia. In phase IIb, the safety will continue to be evaluated, and the efficacy of the Esperanza extract will be explored in combination with chemotherapy in patients with metastatic gastrointestinal tumors (colon, pancreas, stomach, and biliary tract) with newly diagnosed acute leukemias and relapses.

DISEASE(S): Acute Disease,Leukemia, Myeloid,Acute Leukemia Lymphoid,Leukemia,Acute Myeloid Leukemia, In Relapse,Neoplasm, Stomach,Leukemia, Myeloid, Acute,Neoplasms,Acute Myeloid Leukemia,Acute Leukemia,Acute Leukemia In Relapse,Gastric Neoplasms Malignant,Colorectal Neoplasms,Pancreatic Neoplasms,Stomach Neoplasms

PROVIDER: 2751951 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2020-12-31 | GSE140949 | GEO
2023-10-06 | GSE202690 | GEO
2012-05-31 | E-GEOD-30742 | biostudies-arrayexpress
2023-07-07 | GSE154801 | GEO
2019-02-09 | PXD011455 | Pride
2015-07-20 | GSE60031 | GEO
2008-01-21 | GSE9938 | GEO
2024-05-31 | GSE232626 | GEO
2024-04-08 | GSE262899 | GEO
2012-06-01 | GSE30742 | GEO